Your browser doesn't support javascript.
loading
Toward Increased Reliability, Transparency, and Accessibility in Cross-linking Mass Spectrometry.
Leitner, Alexander; Bonvin, Alexandre M J J; Borchers, Christoph H; Chalkley, Robert J; Chamot-Rooke, Julia; Combe, Colin W; Cox, Jürgen; Dong, Meng-Qiu; Fischer, Lutz; Götze, Michael; Gozzo, Fabio C; Heck, Albert J R; Hoopmann, Michael R; Huang, Lan; Ishihama, Yasushi; Jones, Andrew R; Kalisman, Nir; Kohlbacher, Oliver; Mechtler, Karl; Moritz, Robert L; Netz, Eugen; Novak, Petr; Petrotchenko, Evgeniy; Sali, Andrej; Scheltema, Richard A; Schmidt, Carla; Schriemer, David; Sinz, Andrea; Sobott, Frank; Stengel, Florian; Thalassinos, Konstantinos; Urlaub, Henning; Viner, Rosa; Vizcaíno, Juan A; Wilkins, Marc R; Rappsilber, Juri.
Afiliação
  • Leitner A; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: leitner@imsb.biol.ethz.ch.
  • Bonvin AMJJ; Bijvoet Centre for Biomolecular Research, Faculty of Science-Chemistry, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.
  • Borchers CH; University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, BC V8Z 7X8, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 5C2, Canada; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, Mc
  • Chalkley RJ; Department of Pharmaceutical Chemistry, University of California San Francisco, 600 16th Street, Genentech Hall, Suite N472A, San Francisco, CA 94143-2240, USA.
  • Chamot-Rooke J; Institut Pasteur-CNRS USR 2000, Mass Spectrometry for Biology Unit, 28, Rue du Dr. Roux, 75 015 Paris, France.
  • Combe CW; Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, Scotland, UK.
  • Cox J; Computational Systems Biochemistry Research Group, Max-Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.
  • Dong MQ; National Institute of Biological Sciences, Beijing, Beijing 102206, China.
  • Fischer L; Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany.
  • Götze M; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland.
  • Gozzo FC; Institute of Chemistry, University of Campinas, Campinas - SP 13083-970, Brazil.
  • Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht, The Netherlands; Netherlands Proteomics Centre, Utrecht University, 3584 CH Utrecht, The Netherlands.
  • Hoopmann MR; Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.
  • Huang L; Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA 92697, USA.
  • Ishihama Y; Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
  • Jones AR; Institute of Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool L69 7ZB, UK.
  • Kalisman N; Department of Biological Chemistry, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem 91904, Israel.
  • Kohlbacher O; Department of Computer Science, University of Tübingen, Sand 14, 72076 Tübingen, Germany; Institute for Bioinformatics and Medical Informatics, University of Tübingen, Sand 14, 72076 Tübingen, Germany; Institute for Translational Bioinformatics, University Hospital Tübingen, Hoppe-Seyler-Strasse 9,
  • Mechtler K; Research Institute of Molecular Pathology, Campus-Vienna-Biocenter 1, 1030 Vienna, Austria.
  • Moritz RL; Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.
  • Netz E; Department of Computer Science, University of Tübingen, Sand 14, 72076 Tübingen, Germany; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Max-Planck-Ring 5, 72076 Tübingen, Germany.
  • Novak P; Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University, Institute of Microbiology, The Czech Academy of Sciences, 252 50 Vestec, Czech Republic.
  • Petrotchenko E; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.
  • Sali A; Department of Bioengineering and Therapeutic Sciences, Department of Pharmaceutical Chemistry, California Institute for Quantitative Biosciences, University of California, San Francisco, 1700 4th Street, San Francisco, CA 94143, USA.
  • Scheltema RA; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH Utrecht, The Netherlands; Netherlands Proteomics Centre, Utrecht University, 3584 CH Utrecht, The Netherlands.
  • Schmidt C; Interdisciplinary Research Center HALOmem, Institute for Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Strasse 3a, 06120 Halle/Saale, Germany.
  • Schriemer D; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada; Robson DNA Science Centre, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Chemistry, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Sinz A; Department of Pharmaceutical Chemistry & Bioanalytics, Charles Tanford Protein Center, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Strasse 3a, 06120 Halle/Saale, Germany.
  • Sobott F; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK; Department of Chemistry, Biomolecular and Analytical Mass Spectrometry Group, University of Antwerp, Groenenborgerlaan 171, 2020 A
  • Stengel F; University of Konstanz, Department of Biology, Universitätsstrasse 10, 78457 Konstanz, Germany; Konstanz Research School Chemical Biology, University of Konstanz, Universitätsstrasse 10, 78457 Konstanz, Germany.
  • Thalassinos K; Institute of Structural and Molecular Biology, Birkbeck College, University of London, Malet Street, London WC1E 7HX, UK; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
  • Urlaub H; Bioanalytical Mass Spectrometry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.
  • Viner R; Thermo Fisher Scientific, 355 River Oaks Parkway, San Jose CA 95134, USA.
  • Vizcaíno JA; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
  • Wilkins MR; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 2052, Australia.
  • Rappsilber J; Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3BF, Scotland, UK; Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany. Electronic address: juri.rappsilber@tu-berlin.de.
Structure ; 28(11): 1259-1268, 2020 11 03.
Article em En | MEDLINE | ID: mdl-33065067
ABSTRACT
Cross-linking mass spectrometry (MS) has substantially matured as a method over the past 2 decades through parallel development in multiple labs, demonstrating its applicability to protein structure determination, conformation analysis, and mapping protein interactions in complex mixtures. Cross-linking MS has become a much-appreciated and routinely applied tool, especially in structural biology. Therefore, it is timely that the community commits to the development of methodological and reporting standards. This white paper builds on an open process comprising a number of events at community conferences since 2015 and identifies aspects of Cross-linking MS for which guidelines should be developed as part of a Cross-linking MS standards initiative.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectrometria de Massas / Proteínas / Reagentes de Ligações Cruzadas / Proteômica Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectrometria de Massas / Proteínas / Reagentes de Ligações Cruzadas / Proteômica Idioma: En Ano de publicação: 2020 Tipo de documento: Article